Anna Czlonkowska

Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122)

Yongjun Wang, David K. Whynes, Joanna Wardlaw, 2006 .

MicroRNAs as Diagnostic and Prognostic Biomarkers in Ischemic Stroke—A Comprehensive Review and Bioinformatic Analysis

Ciro Indolfi, Salvatore De Rosa, Anna Czlonkowska, 2018, Cells.

Stroke Research Priorities for the Next Decade – A Representative View of the European Scientific Community

Ulrich Dirnagl, Jean-Claude Baron, Britta Engelhardt, 2006, Cerebrovascular Diseases.

Underfunding of Stroke Research: A Europe-Wide Problem

Anna Czlonkowska, Janika Kõrv, Ale Algra, 2004, Stroke.

The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

Peter Sandercock, Joanna Wardlaw, Stefano Ricci, 2008, Trials.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Geoff Cohen, Peter Sandercock, Stefano Ricci, 2012, The Lancet.

Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke Trial

Joanna M. Wardlaw, Eleni Sakka, Geoff Cohen, 2015, Stroke.